Systemic Role for Vitamin D in the Treatment of Psoriasis and Metabolic Syndrome
2011
The Role of Vitamin D in Treating Psoriasis and Metabolic Syndrome
Sample size: 85
publication
Evidence: moderate
Author Information
Author(s): Fu Lisa Wenyang, Vender Ronald
Primary Institution: McMaster University
Hypothesis
Can oral vitamin D be used to treat both psoriasis and metabolic syndrome concurrently?
Conclusion
Vitamin D may help improve psoriasis and metabolic syndrome, suggesting the need for more clinical trials.
Supporting Evidence
- Vitamin D receptors are found in most tissues and cells in the body.
- Psoriasis affects 1–3% of the general population.
- 30.1% prevalence of metabolic syndrome in psoriatic patients compared to 20.6% in controls.
Takeaway
Vitamin D might help people with skin problems and weight issues feel better. Doctors want to study it more to see how it works.
Methodology
The paper reviews existing literature and proposes the use of oral vitamin D based on its effects on inflammation.
Limitations
Few studies have investigated the use of oral vitamin D in patients with psoriasis.
Participant Demographics
Patients with psoriasis and metabolic syndrome.
Statistical Information
P-Value
0.005
Confidence Interval
1.16–2.35
Statistical Significance
p = 0.005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website